AI Buyer Insights:

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Admare Bioinnovations Data, Technology Stack, and Enterprise Applications
AI-Powered Application
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Optibrium Legacy Optibrium Stardrop Predictive Analytics AI-Powered Application n/a 2024 2024
IT Decision Makers and Key Stakeholders at Admare Bioinnovations
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Admare Bioinnovations Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Admare Bioinnovations Technographics

Admare Bioinnovations is a Life Sciences organization based in Canada, with around 150 employees and annual revenues of $20.0 million.

Admare Bioinnovations operates a diverse technology stack with applications such as Optibrium Stardrop, covering areas like Predictive Analytics.

Admare Bioinnovations has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Optibrium.

Admare Bioinnovations recently adopted applications including Optibrium Stardrop in 2024, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Admare Bioinnovations’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Admare Bioinnovations’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Admare Bioinnovations technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.